PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 4, 20240 citationsOpen Access

Figure S5 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

View Full Paper
TGTona M. GilmerCLChun-Hsiang LaiKGKexiao Guo

Key Points

Key points are not available for this paper at this time.

Abstract

Plasma concentrations

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gilmer et al. (2024) studied this question.

synapsesocial.com/papers/68e664bab6db6435875f150ahttps://doi.org/10.1158/1535-7163.25964823.v1
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Figure S6 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors2024
  2. 2Figure S4 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors2024
  3. 3Figure S8 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors2024
  4. 4Figure S2 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors2024
  5. 5Figure S7 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors2024